Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy

Auris Nasus Larynx

Volumn 36, Issue 2, 2009, Pages 199-204

  Taguchi, Takahide ^a   Tsukuda, Mamoru ^a   Mikami, Yasukazu ^a   Matsuda, Hideki ^a   Tanigaki, Yuji ^a   Horiuchi, Choichi ^a   Nishimura, Goshi ^a   Nagao, Jun ichi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Differentiation; Head and neck cancer; Prognostic factors; Treatment results

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; TEGAFUR; URACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HAZARD ASSESSMENT; HEAD AND NECK CARCINOMA; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PROGNOSIS;

EID: 59849085042     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2008.04.003     Document Type: Article

References (16)

1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324 (1991) 1685-1690
2. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., and Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for research and treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88 (1996) 890-899
3. Forastiere A.A., Goepfert H., Maor M., Pajak T.F., Weber R., Morrison W., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
4. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
5. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
6. Taguchi T., Tsukuda M., Mikami Y., Matsuda H., Horiuchi C., Yoshida T., et al. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx. Acta Otolaryngol 126 (2006) 408-413
7. Taguchi T., Ikeda Y., Mikami Y., Kawai S., Arai Y., Mochimatsu I., et al. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma. Anticancer Res 23 (2003) 713-717
8. Seiwert T.Y., and Cohen E.E. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 92 (2005) 1341-1348
9. Brockstein B., Haraf D.J., Rademaker A.W., Kies M.S., Stenson K.M., Rosen F., et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 15 (2004) 1179-1186
10. Wolf G.T., Makuch R.W., and Baker S.R. Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous carcinoma. The Head and Neck Contracts Program. Cancer 54 (1984) 2869-2877
11. Ervin T.J., Clark J.R., Weichselbaum R.R., Fallon B.G., Miller D., Fabian R.L., et al. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 5 (1987) 10-20
12. Ensley J.F., Kish J.A., Weaver A.A., Jacobs J.R., Hassan M., Cummings G., et al. The correlation of specific variables of tumor differentiation with response rate and survival in patients with advanced head and neck cancer treated with induction chemotherapy. Cancer 63 (1989) 1487-1492
13. Johansen L.V., Grau C., and Overgaard J. Squamous cell carcinoma of the nasopharynx-an analysis of treatment results in 149 consecutive patients. Acta Oncol 40 (2001) 801-809
14. Fortin A., Couture C., Doucet R., Albert M., Allard J., and Tetu B. Does histologic grade have a role in the management of head and neck cancers?. J Clin Oncol 19 (2001) 4107-4116
15. Leemans C.R., Tiwari R., Nauta J.J., van der Waal I., and Snow G.B. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71 (1993) 452-456
16. Calhoun K.H., Fulmer P., Weiss R., and Hokanson J.A. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 104 (1994) 1199-1205